Luwen Mu

6PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Metal cluster chemistryHaematological tumoursRadiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 18, 2025
TACE Sequential to Radiofrequency Ablation versus RFA Alone in Hepatocellular Carcinoma Within Milan Criteria.

Huzheng Yan, Chenghao Zhao, Mingming Liu

|May 11, 2022
Chiral ruthenium(ii) complex as potent radiosensitizer of <sup>125</sup>I through DNA-damage-mediated apoptosis.

Mingjun Bai, Zhaolin Zeng, Li Li

|Dec 14, 2021
Arterial Chemotherapy of Oxaliplatin Plus Fluorouracil Versus Sorafenib in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase III Trial (FOHAIC-1).

Ning Lyu, Xun Wang, Ji-Bin Li

|Jul 15, 2021
The Clinical Value of Computed Tomography (CT)-Guided <sup>125</sup>I Brachytherapy for Locally Advanced Non-Small Cell Lung Cancer After Progression of Concurrent Radiochemotherapy.

Zhanwang Xiang, Zhihui Zhong, Luwen Mu

|May 16, 2021
Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma.

Lin Sun, Luwen Mu, Jing Zhou

|May 26, 2017
Percutaneous CT-guided radiofrequency ablation for patients with extrahepatic oligometastases of hepatocellular carcinoma: long-term results.

Luwen Mu, Lin Sun, Tao Pan

Pageof 1

Frequent Collaborators

2 joint publications

Mingsheng Huang

1 joint publications

Ning Lyu

1 joint publications

Shao-Long Li

1 joint publications

Hai-Jing Deng